Phase 2 trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with poor-prognosis, intermediate-grade non-Hodgkin lymphoma: An Eastern Cooperative Oncology Group trial (E3493)
Joseph A. Sparano, Edie Weller, Tipu Nazeer, Thomas Habermann, Ann E. Traynor, Jane Manalo, Peter Cassileth
Research output: Contribution to journal › Article › peer-review
25Scopus
citations
Fingerprint
Dive into the research topics of 'Phase 2 trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with poor-prognosis, intermediate-grade non-Hodgkin lymphoma: An Eastern Cooperative Oncology Group trial (E3493)'. Together they form a unique fingerprint.